Nuevo medicamento para hiperhidrosis.

Glycopyrronium Tosylate May Reduce Sweating Severity And Decrease Sweat Production In Patients With Primary Axillary Hyperhidrosis, Study Suggests.

Dermatology Advisor (9/18, Jacobs) reports researchers found in "2 replicate, randomized, double-blind, vehicle-controlled, 4-week, phase 3 trials" that "the use of daily, topical glycopyrronium tosylate (GT) over the course of 4 weeks reduces sweating severity and decreases sweat production in patients with primary axillary hyperhidrosis." The findings were published in the Journal of the American Academy of Dermatology.

Sent from my iPhone

Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica

Clinica Victoria en San Pedro: 2224-0654
Momentum Escazu: 2101-9574

Please excuse the shortness of this message, as it has been sent from
a mobile device.